1. Home
  2. NTWK vs ICCC Comparison

NTWK vs ICCC Comparison

Compare NTWK & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • ICCC
  • Stock Information
  • Founded
  • NTWK 1997
  • ICCC 1982
  • Country
  • NTWK United States
  • ICCC United States
  • Employees
  • NTWK N/A
  • ICCC N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • ICCC Health Care
  • Exchange
  • NTWK Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • NTWK 56.1M
  • ICCC 55.5M
  • IPO Year
  • NTWK 1998
  • ICCC 1987
  • Fundamental
  • Price
  • NTWK $4.05
  • ICCC $6.16
  • Analyst Decision
  • NTWK
  • ICCC
  • Analyst Count
  • NTWK 0
  • ICCC 0
  • Target Price
  • NTWK N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • NTWK 65.0K
  • ICCC 21.7K
  • Earning Date
  • NTWK 11-11-2025
  • ICCC 11-13-2025
  • Dividend Yield
  • NTWK N/A
  • ICCC N/A
  • EPS Growth
  • NTWK 316.67
  • ICCC N/A
  • EPS
  • NTWK 0.25
  • ICCC 0.20
  • Revenue
  • NTWK $66,088,229.00
  • ICCC $28,274,756.00
  • Revenue This Year
  • NTWK N/A
  • ICCC N/A
  • Revenue Next Year
  • NTWK N/A
  • ICCC N/A
  • P/E Ratio
  • NTWK $16.36
  • ICCC $31.40
  • Revenue Growth
  • NTWK 7.65
  • ICCC 21.75
  • 52 Week Low
  • NTWK $2.14
  • ICCC $3.38
  • 52 Week High
  • NTWK $5.75
  • ICCC $7.60
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 38.06
  • ICCC 47.70
  • Support Level
  • NTWK $3.90
  • ICCC $5.90
  • Resistance Level
  • NTWK $4.21
  • ICCC $6.30
  • Average True Range (ATR)
  • NTWK 0.25
  • ICCC 0.27
  • MACD
  • NTWK -0.05
  • ICCC -0.01
  • Stochastic Oscillator
  • NTWK 15.00
  • ICCC 30.81

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: